| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/19/2013 | CN102228454B Brain targeting via olfactory pathway fragrant essential oil compound and monomer pharmaceutical composition with functions for preventing and treating brain atrophy and activating brain cells |
| 06/19/2013 | CN102198162B Traditional Chinese medicine composition for treating coronary heart disease, and preparation method thereof |
| 06/19/2013 | CN102048804B Medicine prepared from soil-dwelling termite fungus garden serving as main raw material and used for treating hemorrhoid haemorrhage |
| 06/19/2013 | CN101914168B Medical applications and preparation methods of Pleurotus ferulae Lanzi polysaccharide and composites thereof |
| 06/19/2013 | CN101910189B Monosebacate of pyrazole derivative |
| 06/19/2013 | CN101715448B Therapeutic uses of imidazol-5-carboxylic acid derivatives |
| 06/19/2013 | CN101594871B Pyrrolopyrimidine compounds and their uses |
| 06/19/2013 | CN101578271B 4-imidazolines as taar's ligands |
| 06/19/2013 | CN101486701B Analogue compound, and analogue and medical use thereof |
| 06/19/2013 | CN101486700B 8-acetyl chromanone compound, and analogue and medical use thereof |
| 06/19/2013 | CN101411711B Composition containing alisol A and alisol A 24-acetic ester and use |
| 06/19/2013 | CN101224228B Panax notoginseng saponins freeze-dried powder injection and preparing method thereof |
| 06/18/2013 | US8466172 Stabilization of hypoxia inducible factor (HIF) alpha |
| 06/18/2013 | US8466143 Azepine derivatives as pharmaceutical agents |
| 06/18/2013 | US8465758 Drug delivery from stents |
| 06/18/2013 | US8464711 Methods for treating headaches |
| 06/18/2013 | CA2571405C Composition and method for treating hemorrhoids and/or anorectal disorders |
| 06/18/2013 | CA2532800C Anaplastic lymphoma kinase modulators and methods of use |
| 06/18/2013 | CA2438273C Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis |
| 06/18/2013 | CA2418144C Urocortin proteins and uses thereof |
| 06/13/2013 | WO2013086443A1 Agonistic human lcat antigen binding proteins and their use in therapy |
| 06/13/2013 | WO2013085973A1 Treatment for angiogenic disorders |
| 06/13/2013 | WO2013085340A1 Pharmaceutical composition comprising bicyclic pyridinol derivatives for preventing or treating diseases caused by angiogenesis |
| 06/13/2013 | WO2013085017A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013085016A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013084971A1 Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof |
| 06/13/2013 | WO2013084532A1 Prophylactic or therapeutic agent for dysuria |
| 06/13/2013 | WO2013084241A1 Compounds as inhibitors of renin |
| 06/13/2013 | WO2013084089A1 Methods for treating cardiovascular disorder |
| 06/13/2013 | WO2013083286A1 TREATMENT OF ARTERIAL WALL BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR |
| 06/13/2013 | WO2013083070A1 1, 4-dihydro-naphthyridine derivative and pharmaceutical composition and use thereof |
| 06/13/2013 | WO2013083025A1 Composition used in manufacturing of medicaments for treatment of cerebrovascular diseases |
| 06/13/2013 | WO2013083014A1 Daidzein derivative, pharmaceutically acceptable salt and preparation method thereof, and pharmaceutical composition containing same |
| 06/13/2013 | WO2013082756A1 Phosphate transport inhibitors ii |
| 06/13/2013 | WO2013082751A1 Phosphate transport inhibitors i |
| 06/13/2013 | US20130150311 Mixed poloxamer excipients |
| 06/13/2013 | CA2858572A1 Agonistic human lcat antigen binding proteins and their use in therapy |
| 06/13/2013 | CA2858522A1 Methods for treating cardiovascular disorder |
| 06/13/2013 | CA2858164A1 Pyridone derivative and medicine containing same |
| 06/12/2013 | EP2601959A1 Elastase inhibitor |
| 06/12/2013 | EP2601958A1 Use of salvia miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease |
| 06/12/2013 | EP2601954A1 Therapeutic agent for disease |
| 06/12/2013 | EP2601949A2 Pharmaceutical compositions |
| 06/12/2013 | EP2601946A1 Treatment and prevention of diseases related to oxidative stress |
| 06/12/2013 | EP2601200A2 Preparation of prasugrel hydrochloride |
| 06/12/2013 | EP2601180A1 Highly crystalline valsartan |
| 06/12/2013 | EP2600873A1 Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals |
| 06/12/2013 | EP2600865A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 06/12/2013 | EP2600857A2 Treatment of mitochondrial diseases with naphthoquinones |
| 06/12/2013 | EP2178869B1 Indole compounds as an inhibitor of cellular necrosis |
| 06/12/2013 | CN1942588B Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 06/12/2013 | CN1854135B Heteronuclear compound with dicyandiamide connection and its medicinal use |
| 06/12/2013 | CN1461310B ANtibodies that bind human interleukin-18 and methods of making and using |
| 06/12/2013 | CN103154272A Methods and kits for predicting the risk of diabetes associated complications using genetic markers and arrays |
| 06/12/2013 | CN103153996A Quinoline and quinoxaline derivatives as kinase inhibitors |
| 06/12/2013 | CN103153989A Cathepsin s inhibitor compounds |
| 06/12/2013 | CN103153957A N-pyridin-3-yl or N-pyrazin-2-yl carboxamides |
| 06/12/2013 | CN103153320A Oral formulations for counteracting effects of aging |
| 06/12/2013 | CN103146637A Method for preparation of flavone by culturing radix puerariae cells |
| 06/12/2013 | CN103146559A Nutritive health-care wine and preparation method thereof |
| 06/12/2013 | CN103146538A Aloe wine for reducing blood pressure and manufacturing method thereof |
| 06/12/2013 | CN103146532A Black tartary buckwheat red rice flavone wine and production method thereof |
| 06/12/2013 | CN103145738A Imidazo [2,1-b] thiayole derivatives as SIRTUIN modulating compounds |
| 06/12/2013 | CN103145724A Novel iridoids compound and neuroprotective effect thereof |
| 06/12/2013 | CN103145712A Substituted 8-[6-amino-3-pyridyl]xanthenes |
| 06/12/2013 | CN103145706A Imidazopyridine compound with anti-inflammatory action and application thereof to preparation of anti-inflammatory medicament |
| 06/12/2013 | CN103145704A 1,4-dihydro-1,8-nalidixic acid derivatives, their pharmaceutical composition and use of the pharmaceutical composition |
| 06/12/2013 | CN103145697A Nitrobenzimidazole compound, preparation method and application thereof |
| 06/12/2013 | CN103145674A Crystal forms of 7-hydroxyl isoflavone, preparation methods thereof, pharmaceutical composition of methods and purpose |
| 06/12/2013 | CN103145673A Daidzein derivative and pharmaceutically acceptable salt thereof |
| 06/12/2013 | CN103145662A N-substituted animobutyrolactone derivatives and uses thereof |
| 06/12/2013 | CN103145620A Cb1 receptor modulators |
| 06/12/2013 | CN103145608A Anti-enterovirus 71 (EV71) caprolactam compounds, and preparation method and application thereof |
| 06/12/2013 | CN103143055A Use of adipose tissue-derived stromal stem cells in treating fistula |
| 06/12/2013 | CN103143020A Pharmaceutical composition for treating hypertensive left ventricular hypertrophy and application thereof |
| 06/12/2013 | CN103142986A Medicine for treating arrhythmia |
| 06/12/2013 | CN103142956A Medicine for treating viral myocarditis |
| 06/12/2013 | CN103142947A Medicine-induced phlebitis treatment ointment |
| 06/12/2013 | CN103142942A Traditional Chinese medicine composition tablet for treating myocardial infarction and preparation method thereof |
| 06/12/2013 | CN103142941A Traditional Chinese medicine composition capsule for treating myocardial infarction and preparation method thereof |
| 06/12/2013 | CN103142927A Traditional Chinese medicine formula for preserving health and treating multiple diseases |
| 06/12/2013 | CN103142925A Compound Mongolian preparation for treating coronary heart diseases |
| 06/12/2013 | CN103142924A Mongolian medicine compound preparation for treating coronary heart disease |
| 06/12/2013 | CN103142923A Compound mongolian medicine preparation for treating coronary heart disease |
| 06/12/2013 | CN103142904A Traditional Chinese medicine for treating ecthyma leg |
| 06/12/2013 | CN103142884A Traditional Chinese medicine for treating varicosis |
| 06/12/2013 | CN103142876A Preparation capable of improving functions of heart and cerebral vessels and use of oxygen and capable of delaying senescence |
| 06/12/2013 | CN103142866A Traditional Chinese medicine composition for treating cardia-cerebrovascular disease and preparation method thereof |
| 06/12/2013 | CN103142865A Traditional Chinese medicine for treating hypertension |
| 06/12/2013 | CN103142849A Chinese medicine preparation for treating acute vital myocarditis |
| 06/12/2013 | CN103142846A Preparation method of drugs for treating heart diseases |
| 06/12/2013 | CN103142845A Cardiotonic capsule for treating chronic heart failure |
| 06/12/2013 | CN103142838A Chinese medicinal composition for treating hyperlipemia and method for preparing same |
| 06/12/2013 | CN103142835A Traditional Chinese medicine pill for treating arrhythmia |
| 06/12/2013 | CN103142834A Blood pressure reducing Chinese medicine composition and preparation method thereof |
| 06/12/2013 | CN103142819A Traditional Chinese medicine composition for preventing and treating cardiac muscle fibers or myocardial hypertrophy |
| 06/12/2013 | CN103142801A Extraction technology of Lemai particle crude medicines |
| 06/12/2013 | CN103142799A Oral liquid and method for preparing same |
| 06/12/2013 | CN103142781A Chinese medicine composition and preparation thereof for treating chronic heart failure |
| 06/12/2013 | CN103142773A Compound essential oil for gentling breathe and reducing palpitation |